Skip navigation

One Comment

  1. America’s biopharmaceutical research companies are investigating or developing 93 medicines to help the more than five million patients in the United States who are living with Alzheimer’s. The medicines in development – all in either clinical trials or under review by the Food and Drug Administration – include 81 for Alzheimer’s, 11 for cognition disorders and 2 for dementias, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA).

    Alzheimer’s is one of the most complex diseases researchers have ever studied. There are many reasons Alzheimer’s research is so challenging. To start, the brain is the most complex and inaccessible organ in the body and the disease is correspondingly complicated. However, as our understanding of the disease grows so does our ability to find new potential treatment approaches and, ultimately, effective new medicines.

    “Alzheimer’s disease prevents those affected from fighting for themselves, so it’s up to all of us to fight on their behalf,” said PhRMA President and CEO John J. Castellani. “Confronting this devastating disease of the brain will require continued collaboration in the scientific, medical and patient care communities and a commitment by policymakers to support and reward medical innovation.”

    Resources

    Release: From Setbacks to Stepping Stones: Alzheimer’s Disease
    Report (2013): Medicines in Development for Alzheimer’s Diesease (PDF)
    Backgrounder: Selected Medicines in Development for Alzheimer’s Disease
    Alzheimer’s Disease Clinical Trials

    SHAREEMAILPRINT
    Sign-up for Updates

    Subscribe to RSS

    Related Content

    Backgrounder: Selected Medicines in Development for Alzheimer’s
    Read More About Medicines in Development for Alzheimer’s Disease
    From Setbacks to Stepping Stones
    Innovation is a Collaborative Mission
    Rx Minute: Statins Value to Society & Risk Factors Linked to Alzheimer’s
    Rx Minute: Alzheimer’s Burden Will Balloon if New Treatments Are Not Found
    1 of 3next ›
    More On PhRMA — powered by PhRMApedia
    RESOURCES

    Supply Chain Security

    Securing the Supply Chain

    MOST READ

    Press Room

    PhRMApedia Press Room

    RECOMMENDED

    Medicines in Development for Older Americans

    Medicines in Development for Older Americans

    – See more at: http://www.phrma.org/research/medicines-development-alzheimers-disease#sthash.4Hkh2kIa.dpuf
    Source: Pharmaceutical Research and Manufacturers of America WEBSITE http://www.phrma.org/research/medicines-development-alzheimer‘s-disease


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: